![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5666|9|5|612-625
ISSN: 1566-5240
Source: Current Molecular Medicine, Vol.9, Iss.5, 2009-06, pp. : 612-625
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3K/AKT signaling and systemic autoimmunity
Immunologic Research, Vol. 31, Iss. 1, 2005-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3K and negative regulation of TLR signaling
Trends in Immunology, Vol. 24, Iss. 7, 2003-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Liu Hong Mihara Keichiro Song Guoqi Tanaka Hideo Kimura Akiro
Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
Current Molecular Medicine, Vol. 15, Iss. 1, 2015-01 ,pp. :